-+ 0.00%
-+ 0.00%
-+ 0.00%

SCYNEXIS ANNOUNCES FIRST PARTICIPANTS DOSED IN A PHASE 1 SINGLE ASCENDING DOSE AND MULTIPLE ASCENDING DOSE TRIAL OF INTRAVENOUS SCY-247

Reuters·02/26/2026 13:23:29

Please log in to view news